Thomas Marron, MDEnriched profile
Professor of Medicine (Hematology and Medical Oncology) and Professor of Immunology and Immunotherapy; Director, Early Phase Trials Unit (EPTU); Associate Director for Translational Research, Mount Sinai Tisch Cancer Center · Icahn School of Medicine at Mount Sinai / Mount Sinai Tisch Cancer Center
Overview
Updated 14 Jul 2026
Thomas Marron, MD PHD, is Professor of Medicine (Hematology and Medical Oncology) and Professor of Immunology and Immunotherapy at Icahn School of Medicine at Mount Sinai / Mount Sinai Tisch Cancer Center. The public record shows 399 publications with 12,205 citations (h-index 43), centered on Lung Cancer (NSCLC/SCLC), Colorectal Cancer, Hepatobiliary Cancer. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 22 companies, 2 NIH-funded awards (2023–2026).
- Most recent indexed publication: 2026 · Journal for immunotherapy of cancer
- Top research focus: Lung Cancer (NSCLC/SCLC)
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 22 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 32 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Immunoprevention for High-risk Lung Lesions
Sponsor: Robert Samstein
InvestigatorPhase 2RecruitingNCT07284485 - Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Sponsor: Dan Feng
InvestigatorPhase 1/PHASE2Not, yet, recruitingNCT07277322 - A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
Sponsor: Icahn School of Medicine at Mount Sinai
InvestigatorPhase 1RecruitingNCT07058974
Industry payments
Updated 14 Jul 2026
22 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202514 payments$13,296openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year20259 payments
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20251 payment
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 2023–2026 per NIH RePORTER. The latest:
- Breaking the Myeloid-Stromal Axis to Treat Colorectal Cancer
Icahn School of Medicine at Mount Sinai
FY2026$697,131R01CA308427 - Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
Icahn School of Medicine at Mount Sinai
FY2026$658,328R01CA277479 - Type 2 immunity: a primitive response to epithelial injury that shapes bone marrow and lung myeloid crosstalk
Icahn School of Medicine at Mount Sinai
FY2025$658,328R01CA277479
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Expert opinion on burning questions in cancer myeloid cell biology.
Journal for immunotherapy of cancer
2026 - Author Correction: Innovative approaches for lung cancer screening and interception.
Nature reviews. Clinical oncology
2026 - Innovative approaches for lung cancer screening and interception.
Nature reviews. Clinical oncology
2026
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
1468 Madison Ave, Annenberg Building, 24th Floor, New York, NY 10029
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- MD
PhD (Icahn School of Medicine at Mount Sinai)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - Board Certified
Internal Medicine/Medical Oncology (American Board of Internal Medicine)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →zocdoc.com ↗
Editorial & leadership rolesjournal and society appointments
- Director
Early Phase Trials Unit (EPTU), Mount Sinai Tisch Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗ - Associate Director for Translational Research
Mount Sinai Tisch Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.mountsinai.org ↗ - Member
Center for Thoracic Oncology, Mount Sinai (treats NSCLC, SCLC, malignant pleural mesothelioma)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Secondary affiliationsappointments beyond the home institution
- Human Immune Monitoring Center
Icahn School of Medicine at Mount Sinai (affiliated researcher; director is Miriam Merad, not Marron)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗ - Marc and Jennifer Lipschultz Precision Immunology Institute
Icahn School of Medicine at Mount Sinai
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →podcasts.apple.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗
- Podcast guest
BioPlus Specialty Pharmacy "Working in Oncology" podcast/video series, discussing role as Director of Early Phase Trials Unit
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →blog.bioplusrx.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/thomas-marron-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/thomas-marron-8969a252
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
scholars.mssm.edu/en/persons/thomas-marron
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.mssm.edu ↗
Mentions by otherswhere others cite or feature them
- Apple Podcasts
podcasts.apple.com/us/podcast/the-oncology-insights-podcast/id1823946880
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →podcasts.apple.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Pasi Janne, MD, PhD
Harvard University
- 2,385
- publications
- 163
- h-index
- 15
- trials
Julie Brahmer, MD
Bloomberg (United States)
- 855
- publications
- 116
- h-index
- 12
- trials
Enriqueta Felip, MD, PhD
Hebron University
- 1,460
- publications
- 129
- h-index
- 8
- trials
Funda Meric-Bernstam, MD
The University of Texas MD Anderson Cancer Center
- 2,643
- publications
- 148
- h-index
- 8
- trials